[PLX] QoQ Quarter Result on 30-Jun-2013 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-Aug-2013
Financial Year
2013
Quarter
30-Jun-2013 [#Q2]
Profit Trend
QoQ- -58.23%
YoY- -170.91%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
Revenue 7,383 1,122 3,359 3,064 3,968 48 5,390 23.36%
PBT -7,345 -10,885 -5,747 -6,837 -4,321 968 -5,479 21.60%
Tax 38 0 0 0 0 -1,741 -81 -
NP -7,345 -10,885 -5,747 -6,837 -4,321 -9,877 -5,479 21.60%
Tax Rate - - - - - 179.86% - -
Total Cost 14,728 12,007 9,106 9,901 8,289 9,925 10,869 22.47%
Ratio Analysis
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
NP Margin -99.49 -970.14 -171.09 -223.14 -108.90 -20,577.08 -101.65 -1.42%
Per Share
31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 CAGR
EPS -0.08 -1.18 -0.06 -0.07 -0.05 -1.07 -0.06 21.16%
EPS Diluted -0.08 -1.17 -0.06 -0.07 -0.05 -1.07 -0.06 21.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.